TriSalus Life Sciences
TLSI
TLSI
66 hedge funds and large institutions have $202M invested in TriSalus Life Sciences in 2021 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 14 increasing their positions, 11 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
23.85% more ownership
Funds ownership: 57.62% → 81.46% (+24%)
Holders
66
Holding in Top 10
1
Calls
$134K
Puts
–
Top Buyers
| 1 | +$17.3M | |
| 2 | +$17.2M | |
| 3 | +$9.93M | |
| 4 |
GGHC
Gilder Gagnon Howe & Co
New York
|
+$7.04M |
| 5 |
GCL
Glazer Capital LLC
New York
|
+$6.46M |
Top Sellers
| 1 | -$12.1M | |
| 2 | -$3.06M | |
| 3 | -$2.8M | |
| 4 |
Verition Fund Management
Greenwich,
Connecticut
|
-$2.65M |
| 5 |
SCM
Shaolin Capital Management
Miami,
Florida
|
-$2.42M |